Topotecan Not Yet Recruiting Phase 1 / 2 Trials for Neuroblastomas / Leukemia Acute Myeloid Leukemia (AML) / Acute Lymphoblastic Leukaemias (ALL) / Tumors, Solid Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT04106219A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma